Company intelligence
Panome Bio
Better -Omics for Bigger Impact.
About Panome Bio
We give researchers the clarity, speed and insight to discover without limits. Multi-omics with transparency, integrity and impact built in. Next-Generation Metabolomics, Proteomics, Transcriptomics, and Integrated Multi-Omics services. Our integrated approach to multi-omics analysis is the industry leader. We leverage a proprietary dataset integration platform and known connections database to unleash the true power of multi-omics. Our focus is on the customer. Panome Bio provides full transparency. Alongside personalized data reports, we provide all methods and raw data in 4-6 weeks.
Verified activity
Signals from Panome Bio
6 published signals
Research & Knowledge
Panome Bio published an application note demonstrating how Discovery Exposomics and Targeted Exposomics can be combined to characterize chemical exposure profiles across maternal serum and placental tissue.
Reported by Panome Bio
Products & Services
Panome Bio offers Discovery Exposomics and Targeted Exposomics workflows supporting research across pregnancy, neuroscience, toxicology, and human health.
Reported by Panome Bio
Presence & Recognition
Panome Bio is attending the MANA 2026 conference next week with 3 poster presentations, a sponsored lunch presentation, and a table visit.
Reported by Panome Bio
Presence & Recognition
Panome Bio CSO Gary Patti will be participating in the pre-conference workshop,
Reported by Panome Bio
Research & Knowledge
Panome Bio published a blog exploring how surface proteomics helps with target discovery, early safety assessment, biomarker discovery, and resistance research.
Reported by Panome Bio
Research & Knowledge
Panome Bio Senior Director of R&D, Ethan Stancliffe, breaks down how exposomics data reveals signals in complex biological samples in the latest episode of ChatGJP.
Reported by Panome Bio